Desmopressin vs Noopept
Head-to-head comparison of Desmopressin (1-Deamino-8-D-arginine vasopressin) and Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Desmopressin | Noopept |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Full Name | 1-Deamino-8-D-arginine vasopressin | N-phenylacetyl-L-prolylglycine ethyl ester |
| Molecular Weight | 1069.22 Da | 318.37 Da |
| Half-Life | 1.5-3 hours | 20-30 minutes |
| Amino Acids | 9 | N/A |
| Typical Dose | 10-40 mcg intranasal | 10-30 mg/day |
| Route | Intranasal/Oral | Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 35 | 60 |
| Research Status | Clinical | Clinical |
Desmopressin Benefits
- ✓memory consolidation
- ✓reduced pressor burden
- ✓recall support
- ✓short-term learning
Noopept Benefits
- ✓memory recall
- ✓learning efficiency
- ✓attention support
- ✓neurotrophic signaling
Desmopressin Dosing
intranasal research dosing|10-40 mcg or IU-equivalent studies|single-dose protocols
Noopept Dosing
oral research use|10-30 mg per day in human studies|divided or single daily dosing
Desmopressin Side Effects
- ⚠hyponatremia
- ⚠headache
- ⚠nasal irritation
Noopept Side Effects
- ⚠headache
- ⚠irritability
- ⚠sleep disturbance
Research Overview
Desmopressin
The literature is mixed, but desmopressin has shown memory-related effects in selected populations and experimental paradigms. Its cognitive effects are usually discussed as a vasopressin-pathway probe rather than a primary nootropic.
Noopept
Noopept has been reported to increase NGF/BDNF-related signaling and improve performance in tasks involving learning and recall. Evidence includes preclinical studies and small human studies, but the overall literature is still modest compared with mainstream cognitive drugs.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.